Medivolve Announces Change of Auditor
12 Fevereiro 2024 - 8:00PM
Medivolve Inc. (“
Medivolve” or the
“
Company”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC)
announces that it has changed auditors from MNP LLP (“MNP”) to MS
Partners LLP (“MS Partners”), effective February 6, 2024. MNP
resigned as of the effective date of January 16, 2024, and MS
Partners has been appointed as the successor auditor. In accordance
with National Instrument 51‐102 (“NI 51‐102”), the Company has
filed a Change of Auditor Notice on SEDAR+ together with letters
from both MNP and MS Partners, with each letter confirming
agreement with the statements contained in the notice, as
applicable. There were no reportable events (as defined in NI
51‐102) between MNP and the Company.
About Medivolve
Medivolve is a Canadian healthcare
technology company headquartered in Toronto, Canada. The Company’s
mission is to improve health and lives by delivering world-class
diagnostic solutions—starting with COVID-19—as well as to enable
faster and better care to patients through innovative technology.
Medivolve, through its subsidiaries, operates retail patient-care
locations in California.
For investing inquiries, please
contact: David Preiner, CEO, info@medivolve.ca,
702-990-3737.
Medivolve (NEO:MEDV)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Medivolve (NEO:MEDV)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024